Loading
institutionsInstitution
University Hospital Basel / Tumour Centre
University Hospital Basel coordinates cancer care in the home city of Roche and Novartis; its groups run early-phase tumour immunology trials, study breast cancer metastasis, and develop peptide radioligands such as exendin-based imaging of insulinomas.
Also called: USBUniversitätsspital BaselTumorzentrum Basel
Overview
The Tumour Centre of University Hospital Basel coordinates cancer care in a city that is also headquarters to Roche and Novartis and home to the Friedrich Miescher Institute and the University of Basel's Department of Biomedicine. Alfred Zippelius and Heinz Läubli lead tumour immunology and early-phase immunotherapy trials, Mohamed Bentires-Alj studies breast cancer metastasis, Viola Heinzelmann-Schwarz heads gynaecological oncology, and the nuclear medicine and radiopharmaceutical chemistry groups (Damian Wild, Melpomeni Fani) develop novel peptide radioligands, including exendin-based imaging of insulinomas. The hospital runs haematology and CAR-T, thoracic and visceral surgery, and radiotherapy, and hosts SAKK and pharma-sponsored trials.
Location
Basel, CH
Type
hospital · Universität Basel
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#189 · 30 points (0 Newsweek + 0 NCI + 30 from 15 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-17.
Matched to University Hospital of Basel, including child institutions. 544 works · 6,056 citations · 83% open access · 11% clinical trials · 2% reviews.
Oncology works per year
1032022
1072023
1152024
1302025
892026
Most works
- Heinz Läubli42 works
- Alfred Zippelius42 works
- Jakob Passweg28 works
- Mascha Binder24 works
- Viola Heinzelmann‐Schwarz23 works
- Lara Valeska Maul22 works
- Marcus Vetter21 works
- David König21 works
- Elisabeth A. Kappos21 works
- Alexander A. Navarini20 works
Most cited
- Tumour immunology and early-phase immunotherapy
- Radiopharmaceutical chemistry
- Breast cancer metastasis research
- Gynaecological oncology
- Haematology and CAR-T
Astrid Beiglböck
Head of Medical Centres and Executive Director, Tumour Centre
Cancer centre managementInterdisciplinary oncology
Executive Director of the Tumour Centre at University Hospital Basel, coordinating the hospital's organ-specific cancer centres.
Benjamin Kasenda
Senior Physician, Medical Oncology and Haematology (Tumour Centre)
Primary CNS lymphomaGastrointestinal tumoursHaematology-oncology
Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.
Daniel Staub
Representative of University Hospital Basel / Tumour Centre to the Organisation of European Cancer Institutes
Cancer centre representation (OECI)
Daniel Staub represents University Hospital Basel / Tumour Centre in the Organisation of European Cancer Institutes, which lists the centre among its members in Switzerland.
Rakesh Padiyath
Hospital Director (Spitaldirektor) and Chair of Hospital Management
Hospital managementHealth system leadership
Physician-executive who heads University Hospital Basel, Switzerland's oldest university hospital and home to its Tumour Centre.
Similar pages
- InstitutionKing Hussein Cancer Center
Shares PET/CT, Radioligand therapy (beta emitters), HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- IdeaBlunt the inflammation that wakes sleeping cancer cells
Shares Metastasis is understood least and studied last, HR-positive / HER2-negative breast cancer, Non-small-cell lung cancer.
- Key paperNETTER-2: lutetium-177 dotatate as first treatment for higher-grade gastroenteropancreatic neuroendocrine tumours
Shares PET/CT, Radioligand therapy (beta emitters), Novartis, Neuroendocrine tumours.
- TrialA Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
Shares Roche / Genentech, Immune checkpoint inhibitors, Non-small-cell lung cancer.
- PersonRolf A. Stahel
Shares University Hospital Zurich / Comprehensive Cancer Center Zurich, Non-small-cell lung cancer.
- IdeaTreat the body cavity, not the bloodstream, for surface spread
Shares Metastasis is understood least and studied last, CAR-T cell therapy, Ovarian cancer, Immune checkpoint inhibitors.
- InstitutionChulabhorn Hospital / Chulabhorn Royal Academy
Shares PET/CT, Radioligand therapy (beta emitters), Neuroendocrine tumours.
- TreatmentGallium-68 DOTATATE (and Cu-64 DOTATATE)
Shares PET/CT, Radioligand therapy (beta emitters), Novartis, Neuroendocrine tumours.